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Summary 
Costimulatory signals provided by T cells are required for B cells to produce specific antibody 
(Ab) to T-dependent antigen (Ag) bacteriophage r  174. In this study, we demonstrate that 
if cultured in the presence of anti-CD40, interleukin 10 (IL-10),  and Ag, purified B cells can 
produce antiphage Ab in quantities comparable to those synthesized by B cells cocultured with 
Ag and T cells. Isotypes produced by B cells in this culture system correspond to those observed 
in sera of B cell donors. Culture of immunoglobulin (Ig)D-  and IgD + B cells reveals that Ag- 
induced production of antiphage Ab is restricted to IgD-  subset of B cells. In the absence of 
Ag, anti-CD40/IL-10-stimulated B cells produce only minute amounts of antiphage Ab, indicating 
that Ag stimulation is indispensable and provides a signal that is synergistic with anti-CD40 
and IL-10.  Addition of a soluble form of the CD40 ligand (sgp39)  to the culture system has 
a similar effect on specific Ab synthesis as anti-CD40; addition of the soluble construct, CD40 
Ig, known to inhibit gp39/CD40 interaction, suppresses in vitro antiphage Ab production by 
Ag exposed peripheral blood mononuclear cells. Finally, in vivo requirement of gp39/CD40 
interaction for specific Ab production was demonstrated by the finding that activated T  cells 
from patients with x-linked hyper IgM syndrome express functionally defective gp39 and respond 
with depressed Ab titers and fail to switch from IgM to IgG after multiple phage immunizations. 
These observations illustrate that in vitro and possibly in vivo Ag-specific Ab synthesis requires 
the presence of Ag and IL-10,  and activation signals via CD40. 
H 
elper T cells provide stimulatory signals that induce B 
cell proliferation and differentiation into Ig-producing 
cells. These stimulatory signals are transmitted through ei- 
ther cognate or noncognate mechanisms (1). Cognate inter- 
action, which requires direct contact between B and T cells, 
provides the initial signals for B cell activation.  Cytokines 
produced by helper T cells are known to transmit a second 
signal by noncognate mechanisms. Both cognate and non- 
cognate stimuli are necessary  to activate and differentiate resting 
B cells into terminal Ig-secreting cells (1). 
Recently, two molecules, CD40 and CD40 ligand (gp39), 
involved in a cognate help were identified on B cells (CD40) 
and on activated T  helper cells (CD40L, gp39) (2-4). The 
importance of CD40 for B cell activation was underscored 
by demonstrating that anti-CD40, as well as a soluble recom- 
binant form of gp39, initiates B cell proliferation and differen- 
tiation into Ig-producing cells in the presence of cytokines 
(5-7). If cultured with IL-4, anti-CD40-activated B cells pro- 
duce IgE and IgG4, while in the presence of IL-10 they syn- 
thesize IgG, IgA, and IgM (5, 6). Thus, the combination 
of anti-CD40 and cytokines provide both cognate and non- 
cognate stimulator), signals, which can substitute for T cell 
help to B cells. However, the role of CD40 and these cytokines 
in the Ag-specific Ab production is not well understood. To 
investigate this, we used the T cell-dependent Ag, bacterio- 
phage r  174 (phage) (8-10), which allows us to study the 
induction and regulation of phage-specific  Ab synthesis. 
Materials and Methods 
Reagents.  Purified  anti-CD40 mAb (G28-5 [IgG1]) was kindly 
provided  by Dr. Edward A. Clark (Seattle, WA) (2). Purified  human 
rlL-4 and rlL-10 were gifts from Dr. K. W. Moore, Dr. H. Ishida, 
and Dr. M. Howard (DNAX, Palo Alto, CA). The soluble fusion 
protein of the extracellular domain of human CD40 coupled with 
the Fc domain of human IgG1 (CD40 Ig), the soluble form of 
Leu-8 coupled with the same Ig fragment (Leu-8 Ig), (11) and su- 
pernatants of COS cells expressing  soluble  gp39 (sgp39) or soluble 
CD72 (sCD72) were generated as previously described (7). 
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ripheral blood B cells and T  cells were isolated as previously de- 
scribed  (12). To obtain IgD-  and IgD + B cells, purified B cells 
stained with FITC-conjugated anti-human IgD (Tago, Inc., Burlin- 
game, CA) and PE-conjugated anti-CD19 (Leu-12; Becton Dick- 
inson & Co., Mountain View, CA) were sorted into IgD-  Leu- 
12 + and IgD + Leu-12 + B cells by FACStar ® (Becton Dickinson 
& Co.). The final purity of both subsets  was  >99.7%. 
B cells were cultured in 96-weU plates at a final volume of 200 
/xl in RPMI 1640 supplemented with 10% FCS (HyClone Labora- 
tories, Logan, UT), 2 mM ghtamine, 50 U/ml penicillin,  and 50 
gg/ml of streptomycin. The cell concentration of B cells was 2.5 
x  10S/ml; in some experiments B cells were cultured in the pres- 
ence of 106/ml of autologous T  cells, mAb G28-5 (final concen- 
tration, 1/~g/ml), soluble gp39, soluble CD72 (diluted 1:4), Ibl0 
(10 ng/ml), and phage (l& PFU/ml) were added on day 0. In the 
blocking experiments, CD40-Ig or Leu-8 Ig was added on day 0 
at various concentrations. After 12 d, the supernatants were col- 
lected and tested for Ig concentrations by ELISA (13) and phage- 
neutralizing Ab activity (8). 
Bacteriophage ¢bx174, Immunization Protocol, and Ab Determina- 
tion.  A single lot of phage prepared as previously described  (8) 
was used for in vivo immunizations and for the in vitro experi- 
ments.  Human volunteers and four patients from three families 
with x-linked hyper IgM syndrome were injected intravenously 
twice, 6 wk apart, with phage at the standard dose of 2  x  109 
PFU/kg body weight. Serum was collected before and at weekly 
intervals after immunizations and antiphage Ab activity determined 
by a sensitive phage neutralization assay, expressed as the rate of 
phage inactivation (K value, Kv) (8). Using this method, the lower 
limit of sensitivity in detecting phage-neutralizing Ab is a K value 
of 0.01. Susceptibility of phage-neutralizing Ab to 2-ME was de- 
termined by the method of Grubb and Swahn (14); neutralizing 
Ab resistant to 2-ME was considered to be IgG. 
Results 
Production of  Antiphage Ab by Human B Cells.  Purified B 
cells obtained from human subjects 6 wk or later after the 
last immunization with phage failed to produce spontaneous 
antiphage Ab in the absence of Ag, indicating that they were 
in a resting stage (Fig.  1).  Addition of Ag (phage) to cul- 
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Figure  1.  Antiphage  Ab production by purified human B cells. B cells 
(0.5  x  10S/well)  were cultured alone or with various combinations of 
Ag (phage), IL-10, anti-CD40, or autologous T cells. Mean and 1 SD of 
triplicate cultures are shown. 
tured B cells failed to induce phage-specific Ab production. 
Autologous T cells efficiently initiated the production of an- 
tiphage Ab by Ag-stimulated B ceils, demonstrating that T 
cell help is necessary for the induction of phage-specific Ab 
production. Ag-stimulated B cells, in the absence of T  cells 
and cocultured with a combination of anti-CD40 and IL-10, 
produced amounts of antiphage Ab similar to cultures to which 
autologous T  cells were added.  Neither anti-CD40 nor IL- 
l0 alone induced specific Ab production by Ag-stimulated 
B cells, indicating that combination of anti-CD40 and IL-10 
is required for specific Ab production.  IL-4, known  to in- 
duce anti-CD40-stimulated B ceils to proliferate and to poly- 
clonally produced Ig (5), had no effect on phage-specific Ab 
production. 
The requirement of Ag for specific Ab production is shown 
in Table 1. In the absence of Ag, B cells cultured with anti- 
CD40 and IL-10 produced only minute amounts of antiphage 
Table  1.  Effect  of Ag Stimulation on the Production of Antiphage Ab 
Stimulation  Antiphage Ab titer 
Cells  Ag (phage)  anti-CD40 + IL-10  Exp.1  Exp.2  Exp.3 
B cells  None  None  <0.01  <0.01  <0.01 
None  +  0.17  +_ 0.004  0.02  _+ 0.005  0.02  +_ 0.002 
+  None  0.03  -+  0.031  0.03  _+ 0.019  0.17  _+ 0.004 
+  +  4.24  _+  1.311  2.70  _+ 0.676  2.20  _+ 0.865 
B + T  ceils  None  None  <0.01  <0.01  <0.01 
+  None  4.50  _+ 0.670  3.26  _+ 0.544  8.38  _+  2.531 
Purified human B cells, or B and autologous T cells, were cultured for 12 d with various combinations of Ag (phage) or anti-CD40 and IL-10. 
Data are shown as mean  +  SD of the results obtained from triplicate cultures. 
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Primary immunization  Secondary immunization 
Donor 1  Donor 2  Donor 1  Donor 2 
Kv 
Sera  12.02 (0.8)*  7.61 (0.3)  158.24 (86.1)  118.65 (81.8) 
Culture supernatants*  0.64 (0.7)  0.50 (0)  2.85 (65.0)  1.59 (87.4) 
Peripheral blood was collected from two human volunteers 6 wk after primary or secondary  immunization. 
" Total neutralizing Ab titer (percent IgG). 
B cells were cultured for 12 d with anti-CD40 and IL-10 in the presence of phage Ag. Means of triplicate cultures are shown. SD <15% of the 
mean for each point. 
Table  3.  Antiphage  Ab Synthesized by IgD + and IgD-  B cells 
Total  Total 
Cells  Stimulation  IgM  IgG  Antiphage Ab 
ng/ml  ng/ml  Kv 
IgD § B cells  None  <30  <30  <0.01 
Anti-CD40+ IL-10  372  _+  48  <30  <0.01 
IgD-  B cells  None  40  _+  1  314  _+  44  <0.01 
Anti-CD40+IL-10  188  _+  12  1,790  _+  647  2.59  +_  0.99* 
Human peripheral blood B cells obtained  from a fully  immunized  volunteer  (serum Kv = 98.0 [52% IgG and 48% IgM]) were sorted into Leu-12  + 
IgD § cells and Leu-12  + IgD- cells by FACStar  |  The cells were cultured with or without anti-CD40 and IL-10 for 12 d in the presence of Ag 
(phage). Data are shown as mean _+ SD obtained from triplicate cultures. Similar results were obtained by three independent experiments. 
* The phage-specific Ab consisted of IgG (56%) and IgM (44%). 
Ab.  Similarly,  B cells cultured with autologous T  cells in 
the absence of Ag failed to produce detectable antiphage Ab. 
However, addition of Ag to B cells cultured in the presence 
of anti-CD40 and IL-10 resulted in the production of high 
titers of phage-neutralizing Ab, reaching K values (Kv) that 
were comparable (26-94%)  to those of B cells cultured in 
the presence  of Ag and autologous T  cells. 
Isotypes of  An@hage Ab Produced  by Human B Cells.  Serum 
antiphage Ab produced in response to a primary immuniza- 
tion with phage consists mainly of the IgM isotype and in 
response to a secondary immunization, when class switch 
has occurred, mainly of the IgG isotype (8, 9) (Table 2). We 
measured the IgG proportion of in vitro antiphage Ab pro- 
duced by B cells after primary and secondary immunization. 
Phage-specific  Ab  produced  in  vitro  by  anti-CD40/IL- 
10-stimulated B cells obtained from volunteers after primary 
immunization was predominantly of the IgM isotype, and 
after secondary immunization, predominantly of the IgG iso- 
type, reflecting the isotype of phage-specific  Ab observed in 
the B cell donor's serum. These results indicate that IL-10 
has very little effect, if any, on heavy chain switching, but 
has a profound effect on the amount of Ab produced by Ag- 
specific B cells. 
Production of Antiphage Ab by IgD- B Cells.  B cells ob- 
tained from a fully immunized volunteer were further sepa- 
rated into Leu-12 + IgD + ceils and Leu-12 + IgD- cells using 
flow cytometry. Serum antiphage Ab of the twice-immunized 
human donor used in this experiment consisted of 52% IgG 
and 48% IgM. As shown in Table 3, IgD-  B ceUs synthe- 
sized antiphage Ab if cultured in the presence of Ag, anti- 
CD40, and IL-10, indicating that highly purified B cells can 
synthesize Ag-speciflc Ab in this culture system. The antiphage 
Ab produced in vitro was 56% IgG and 44% IgM, demon- 
strating that both IgG- and IgM-committed cells in IgD- 
B cells were activated under these conditions. In contrast, 
IgD + B cells failed to produce antiphage Ab although they 
responded to stimulation with anti-CD40 and IL-10 by in- 
creased production of total IgM. These results confirm the 
observation by Jelinek et al. (15) that Ag-induced memory 
B cells are contained in the IgD-  subset and that naive B 
calls are part of the IgD + subset. 
Effect of  Sohble gp39 and CD40 Ig on Antiphage Ab Produc- 
tion.  The ligand for CD40 (gp39)  expressed  by activated 
T cells was recently identified (7, 13). Soluble gp39 (sgp39) 
is known to bind to CD40 and to provide costimulatory signals 
to B cells (7).  As shown in Fig.  2,  sgp39,  similar to anti- 
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Figure 2.  Effect of soluble gp39 (sgp39) on the production of phage- 
specific Ab. Purified B cells obtained from an immunized human volun- 
teer were cultured with various combinations of Ag (phage),  IL-10 (10 
ng/ml), anti-CD40 (1 ~g/ml), soluble gp39 (1:4 dilution), or soluble CD72 
(1:4 dilution). Mean and 1 SD of triplicate cultures are shown. 
CD40, induced antiphage Ab production by B cells costimu- 
lated with Ag and IL-10. A control fusion protein, sCD72, 
had no effect on phage-specific  Ab production. 
Soluble CD40 Ig has been shown to inhibit the interac- 
tion between gp39 (CD40 ligand) expressed on activated T 
cells and CD40 expressed constitutively on B cells by com- 
petitive binding to gp39. To explore the effect of this con- 
struct on antiphage Ab production by primed lymphocytes, 
we cultured PBMC obtained from fully immunized volun- 
teers in the presence of Ag and soluble CD40 Ig. Antiphage 
Ab production was suppressed in a dose-dependent manner 
(Fig.  3).  In contrast, spontaneous in vitro IgG production 
was not suppressed by the addition of soluble CD40 Ig, indi- 
cating that the suppressive effect of soluble CD40 Ig is not 
caused by a toxic effect on B cells (data not shown). This 
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+ Ag + LeuS-Ig (I0), 
+ Ag § CD40-Ig (4)  ~ 
+ Ag + CD40-Ig (20) 
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Antibody  titer  (Kv) 
Figure 3.  Effect  ofCD40 lg on phage-specific  Ab production by PBMC. 
PBMC (2  x  106/ml) obtained from an immunized human volunteer were 
cultured with Ag (phage) and various concentrations of CD40 Ig (4-20 
/~g/ml) or Leu-8 Ig (10/~g/ml). 
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Figure 4.  In vivo production of phage-neutralizing Ab in normal humans 
and patients with hyper IgM syndrome. Normal males (n  =  12) (-0--, 
geometric mean; ....... , _+ SD) and patients with x-linked hyper IgM syn- 
drome and functionally defective gp39 (n  =  4) (O, A, D, ~) were im- 
munized with phage twice 6 wk apart (arrows). Mean percent IgG of an- 
tiphage Ab in serum collected 2 wk post-secondary immunization was 
49%  in controls and 0%  in all hyper IgM patients. 
is further confirmed by the observation that soluble Leu-8 
Ig used as control fusion protein had no suppressive effect 
on phage-specific Ab production. These observations dem- 
onstrate that stimulation of CD40 by gp39 plays an impor- 
tant role in specific Ab production in vitro. 
Ab Responses to Bacteriophage ckX174 in the Hyper IgM Syn- 
drome.  To demonstrate the in vivo role of CD40 for specific 
Ab production, patients with X-linked hyper IgM syndrome 
due to nonfunctioning gp39 (13) were immunized with bac- 
teriophage ~X174. As shown in Fig. 4, all four patients had 
depressed primary and secondary Ab responses, characterized 
by lack of amplification and inability to switch from IgM 
to IgG isotypes.  In normal male controls (n  =  12), 49% 
of phage neutralizing Ab present in serum 2 wk after sec- 
ondary immunization is of the IgG isotype. In contrast, none 
of the four hyper IgM patients had detectable antiphage Ab 
of the IgG class. 
Discussion 
The T cell-dependent Ag, bacteriophage ~bx174, is a useful 
tool to study immunologic  responses in normal and immune- 
deficient subjects (8-10, 16). Immunodeficient  patients with 
severe T lymphopenia  (subgroup of DiGeorge syndrome, aden- 
osine deaminase defidency) or with functionally abnormal 
T cells (subset of common variable immunodeficiency) have 
a depressed Ab response with defective amplification and class 
switch, indicating the essential role of T cell help in the syn- 
thesis of antiphage Ab in vivo (8, 16). In vitro synthesis of 
antiphage Ab by Ag-stimulated PBMC from immunized 
human subjects has been demonstrated (10). However, purified 
B cells cultured with Ag produce only minute amounts of 
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quired for specific Ab production in vitro (10). In this study 
we demonstrated that, if anti-CD40 and IL-10 are added to 
the culture system, Ag-specific Ab production by purifed 
B cells occurs.  The amount of phage-specific Ab produced 
by B cells stimulated with anti-CD40/IL-lO and Ag is com- 
parable to that produced by PBMC cultured in the presence 
of Ag, suggesting that anti-CD40/IL-lO substitutes the help 
provided by T cells and/or macrophage in this in vitro system 
of specific Ab production. 
The binding in our in vitro system of anti-CD40 or sgp39 
to CD40 initiates signals that will lead to B cell activation; 
the interaction between gp39 and CD40 in vivo is consid- 
ered to represent contact-dependent T cell help to B cells (7, 
13,  17). The critical  role of gp39/CD40 interaction in the 
induction of Ag-specific Ab production is underscored by 
our observation that anti-CD40 as well as a soluble form of 
gp39 induces phage-specific Ab production by purified B cells. 
Furthermore, CD40 Ig, if added to the culture system, in- 
hibits the production of antiphage Ab, presumably by binding 
to its ligand, gp39, and thus interfering with the binding 
of the T cell ligand with its B cell counterpart (7). In addi- 
tion, our observation that patients with the x-linked hyper 
IgM syndrome, due to functionally defective gp39 (13), re- 
spond to phage immunization with depressed Ab titers, lack 
of amplification, and failure to switch from IgM to IgG pro- 
vides further evidence for the important role the gp39/CD40 
signaling system plays in the induction of in vivo Ag-specific 
Ab production. These results indicate that expression of func- 
tional gp39 is required for amplification and isotype switching 
as part of the proper Ag-specific Ab response.  Since T cell 
stimulation via CD3 induces gp39 expression (17), it is likely 
that interaction of the TCR. with Ag-derived peptide presented 
by APC induces gp39 expression by these activated T cells. 
It is thus possible that under physiologic conditions induc- 
tion of gp39 is regulated tightly and limited to Ag-directed 
cognate T/B cell interaction. 
The involvement of IL-10, a potent growth and differenti- 
ation factor for human B lymphocytes (6), in Ag-specific Ab 
production is evident by our observation that B cells cultured 
with Ag and anti-CD40 produce phage-specific Ab only if 
IL-IO is added to the system. Consistent with our hypoth- 
esis that IL-10 plays an important role in Ag-specific  Ab 
production in vivo is the observation that IL-10 mRNA is 
upregulated 100-fold in spleen cells during the primary im- 
mune response of mice to goat anti-mouse IgD Ab (18). Al- 
though IL-4, similar to IL-IO, induces proliferation and poly- 
clonal Ig production in anti-CD40-activated B cells (6, 13), 
IL-4 failed to induce antiphage Ab synthesis in vitro. This 
failure may be explained by the fact that antiphage Ab con- 
sists mostly of IgM and IgG (IgG1,  IgG2, and IgG3, but 
very little, if any, IgG4) isotype (9), and IL-4 induces mainly 
IgE and IgG4 subclass synthesis (5), while IL-10 effectively 
causes production of IgM, IgA, and IgG of all four IgG sub- 
classes (6; S. Nonoyama, unpublished observation). 
B cells, exposed to a combination of anti-CD40 and IL-10 
in the of Ag, secrete large amounts of all Ig isotypes (except 
IgE), but only minute amounts of phage-specific Ab. How- 
ever, if Ag is added to the system, antiphage Ab synthesis 
is greatly increased, indicating that Ag stimulation has a syn- 
ergistic effect. These results are consistent with previous reports 
that anti-Ig and anti-CD40 are comitogenic in B cell activa- 
tion (2), and that B cell activation through crosslinking of 
surface Ig is enhanced by IL-10 (6). Considering that surface 
Ig is the only receptor that transmits Ag-specific signals to 
B cells, we postulate that Ag stimulation provides the initial 
signal that renders Ag-specific B cells more receptive for the 
subsequent helper signals by anti-CD40 and IL-10. 
The establishment of a B cell culture system producing 
Ag-specific Ab has allowed us to study molecules involved 
in activating Ag-primed memory B  cells. Ag-specific  Ab 
production by primed B cells depends on three signals: Ag, 
anti-CD40, and IL-10.  In the absence of any one of these 
reagents,  B cells fail to produce specific Ab, suggesting that 
each component provides a distinct and synergistic signal to 
B cells. 
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